|
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - December 2022
Anthony Fauci Quietly Shocked Us All
Dec. 31, 2022 - By Peter Staley - The first time I met Dr. Anthony Fauci was at the International AIDS Conference in Montreal during the summer of 1989. ACT UP, the AIDS activist group I was a part of, had scared the bejesus out of conference organizers by seizing the stage during the opening session, then made things worse by disrupting various scientific presentations. Many, if not most, AIDS researchers wanted us hauled away and never heard from again. Little did they know that Dr. Fauci, who was leading the response at the National Institutes of Health, had been meeting with members of ACT UP since shortly after our founding two years earlier.
Read more...
HIV tests used at Montreal hospitals recalled after suspect results noticed
Dec. 29, 2022 - Cindy Sherwin - The McGill University Health Centre (MUHC) has identified approximately 9,000 patients who may have received false negatives through recalled HIV tests, but the health centre maintains the risk of error is extremely low.
Read more...
Six Truths About STI Immunity Myths
Dec. 23, 2022 - Gigi Engle - The sexual health information that people receive is depressing at best and dangerous at worst. We learn that sexually transmitted infections (STIs) are shameful, wrong, and make us dirty. This just isn’t true. STIs are a part of being sexually active. Due to all the stigma, people are not given scientifically robust information and are therefore more at risk of transmitting and contracting STIs.
Read more...
American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability
American Gene™ Plans for Phase 2 Trial of AGT103-T
Dec 22, 2022 - American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secondary endpoints of its AGT103-T Phase 1 trial. The Phase 1 trial demonstrated that AGT103-T — an autologous T cell product that has been modified with the AGT103 lentiviral vector for HIV resistance — was well-tolerated in humans and that these enhanced T cells persist in the body, ready to respond to HIV. Data from this first-in-human study of AGT103-T has been published in Frontiers.
A CALL TO ARTISTS AHEAD OF INTERNATIONAL HIV CONFERENCE
Dec 22, 2022 - by Rick Guasco - Artists and scientists to be paired up for exhibit in Brisbane for IAS 2023
HIV SCIENCE AS ART EXHIBIT
Artists from around the world who are living with HIV are invited to apply to an art exhibition that will pair them with scientists presenting at the IAS 2023 conference in Brisbane, Australia, July 23–26. The exhibit, HIV Science as Art, will spotlight new and innovative science. Twelves artists will be commissioned to create an original work of art in collaboration with their partner scientist reflecting the concepts of the scientific work. The artwork will be created over a 90-day period in March through May.
Sunlenca® (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for People Living With Multi-Drug Resistant HIV
FOSTER CITY, Calif.--(BUSINESS WIRE)-- December 22, 2022 - – Sunlenca is the First and Only Approved Capsid Inhibitor-Based HIV Treatment Option –
- New Drug Application Approval Based on High Rates of Sustained Virologic Suppression in the CAPELLA Trial -
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) HIV-1 infection. Sunlenca has a multi-stage mechanism of action distinguishable from other currently approved classes of antiviral agents and no known cross resistance exhibited in vitro to other existing drug classes. Sunlenca offers a new, twice-yearly treatment option for adults with HIV that is not adequately controlled by their current treatment regimen.
A promising new way to prevent HIV infections
22 Dec. 2022 - Moira Wyton - Why a new injectable drug is a breakthrough, and how Canadian scientists are improving access to it.
Long-acting pre-exposure prophylaxis, or PrEP, is more than 99 per cent effective at preventing the development of HIV when it is injected every two months, according to clinical trial data reported by manufacturer ViiV Healthcare.
The injectable drug, cabotegravir, was approved by the U.S. Food and Drug Administration last December but has not yet been submitted to Health Canada for approval.
Read more...
UPEI joins initiative to end HIV in Canada
Dec.21, 2022 - Kevin Yarr - Anonymity at the centre of program
UPEI has signed an agreement with Canada's I'm Ready to Know initiative, which aims to eradicate HIV in Canada by improving access to testing.
The initiative distributes easy-to-use tests, which have been available at UPEI since earlier this month.
Read more...
Annual Epidemiological Report 2021: Lowest number of recorded hepatitis A cases, five other food and waterborne diseases rising towards pre-pandemic levels
Stockholm, 20 December, 2022 - Hepatitis A cases in 2021 were at their lowest levels since EU-level hepatitis A surveillance began in 2007, while five other food and waterborne diseases are rising towards pre-pandemic levels. The information is presented in the Annual Epidemiological Report 2021, of which six new chapters are published today by ECDC.
Annual Epidemiological Report 2021: Lowest number of recorded hepatitis A cases, five other food and waterborne diseases rising towards pre-pandemic levels
Stockholm, 20 December, 2022 - Hepatitis A cases in 2021 were at their lowest levels since EU-level hepatitis A surveillance began in 2007, while five other food and waterborne diseases are rising towards pre-pandemic levels. The information is presented in the Annual Epidemiological Report 2021, of which six new chapters are published today by ECDC.
UNAIDS welcomes Kenya’s High Court judgement in landmark case of involuntary sterilization of women living with HIV
GENEVA, 20 December 2022 - UNAIDS welcomes the judgement by the High Court of Kenya at Nairobi recognizing that coerced sterilization of women living with HIV is a violation of their human rights.
The judgement follows a case brought forward in 2014 by a Kenyan woman living with HIV who was coerced by professionals at a health facility to undergo tubal ligation thus taking away her ability to have children. The High Court found that the performance of this operation without consent amounted to a violation of her rights to non-discrimination, to dignity, to health and to family.
HIV-Associated Conditions in Older Adults
December 18, 2022 - Geriatric practices will see more people living with human immunodeficiency virus (HIV), as their life expectancy is close to the general population due to effective antiretroviral therapy (ART). Geriatricians focus more on HIV-associated, non-acquired immunodeficiency syndrome (AIDS) disorders than HIV alone. We will review the most common chronic illnesses and conditions associated with aging and HIV.
Long-acting injectable PrEP is a big step forward in HIV prevention
December 18, 2022 - The number of new HIV infections has not changed much over the past couple of decades and approximately 13 per cent of people living with HIV in Canada are undiagnosed. This demonstrates the need for more HIV prevention strategies.
While long-acting injectable PrEP is new, oral PrEP — a pill taken either daily or around sexual activity — was approved in the U.S. back in 2012. Canada only approved oral PrEP in 2016. And we are once again falling behind the U.S. on making injectable PrEP available here.
UNAIDS Board members commit to bold action to ensure the end of AIDS
December 16, 2022 - The 51st meeting of the UNAIDS Programme Coordinating Board concluded today, with commitments to bold action to get the world on track to end AIDS by 2030. The meeting, which brings together member states, civil society and UN agencies, saw a series of pledges made and agreements for joint work which will tackle the inequalities which drive the AIDS pandemic.
Dooley honored by Treatment Action Group
Dec. 15, 2022 - by Paul Govern - Kelly Dooley, MD, PhD, MPH, professor of Medicine and Pathology, Microbiology and Immunology, who joined Vanderbilt University Medical Center in September as director of the Division of Infectious Diseases, has received the Research in Action Award from the Treatment Action Group (TAG). The award ceremony was held Nov. 14 in New York City.
Formed in 1992, TAG is a community-based think tank that seeks to accelerate research into HIV, tuberculosis, and hepatitis-C. The organization’s Research in Action Award honors individuals who have made historic contributions toward ending these pandemics.
Pandemics can only be defeated if communities are supported to lead, say governments, NGOs and UN
CHIANG MAI, THAILAND, 15 December 2022 - Community-led responses are a critical part of the AIDS pandemic response, and must be prioritised in resourcing. The approach, set out by governments, civil society organisations and United Nations agencies at an international meeting on AIDS in Chiang Mai, Thailand, will also be key for tackling other pandemics and for preparing for the pandemics to come, delegates said. The meeting saw the first international definition of a community-led response to a pandemic, published after a two-year consultative process that brought together 11 governments, representing each region of the world, and 11 civil society representatives. This UNAIDS multi-stakeholder task team on community-led responses was co-convened by the World Health Organization and United Nations Development Programme, and presented outcomes to the 51st Programme Coordinating Board meeting of the UN Joint Programme on HIV and AIDS.
HIV/AIDS advocate and her family work to promote testing and fight stigma. ‘I feel like I’m not just existing, that I’m living.’
Dec. 14, 2022 -By Jake Sheridan and Deanese Williams-Harris - Eighteen years ago, Chatrivia Kennedy learned she was HIV positive when her partner was hospitalized with an HIV-related illness. She was eight months pregnant.
She suffered in silence for many years, but eventually gained the courage to disclose her status on World AIDS Day 2018 in a video posted on YouTube, 14 years after her diagnoses.
Read more...
Mpox, AIDS and COVID-19 show the challenges of targeting public health messaging to specific groups without causing stigma
December 14, 2022 - Ken Ho, University of Pittsburgh Health Sciences - During infectious disease outbreaks, clinicians and public health officials are tasked with providing accurate guidance for the public on how to stay safe and protect themselves and their loved ones. However, sensationalized media coverage can distort how the public perceives new emerging infections, including where they come from and how they spread. This can foster fear and stigma, especially toward communities that are already mistrustful of the health care system.
The racial and sexual stigma surrounding monkeypox is what spurred the World Health Organization to rename the disease to mpox in November 2022. While this is a step in the right direction, I believe more work needs to be done to reduce the stigma surrounding infectious diseases like mpox.
NIH Grant Funds Antibiotic Trial for Patients with HIV and Emphysema
DECEMBER 13, 2022 - Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study whether the antibiotic doxycycline may slow the progression of the chronic lung disease emphysema in people living with well-controlled HIV.
“There are no available treatments for addressing emphysema progression. Inhalers commonly prescribed to patients with the disease only alleviate airway symptoms,” said co-principal investigator Dr. Robert Kaner, an associate professor of genetic and clinical medicine at Weill Cornell Medicine and an associate attending physician at the NewYork-Presbyterian/Weill Cornell Medical Center. “If doxycycline can slow the lung damage caused by emphysema, it would be a landmark finding.”
“The stigma is real but it won’t stop us”: HIV-positive mothers put their children’s health first in Nigeria
13 December 2022 - by Ijeoma Ukazu - In Mushin, Lagos State, mothers living with HIV are not letting their status and stigma deny their children full immunisation coverage.
HIV infection remains a major public health challenge in Nigeria with age-long stigma a cause for concern. This has resulted in low immunisation status for infants whose mothers are living with the virus. But mothers in Mushin are not going to let this be the reason they don't get full immunisation coverage for their children.
"Being HIV-positive comes with a lot of stigma and challenges, but I look past that and put efforts [in] daily to ensure my child gets all the immunisation cover she deserves," says Adetunji Bimpe (18), mother of one.
'Fauci effect' diminishes as infectious diseases specialty yields low interest
December 13, 2022 - by Erica Carbajal - New physicians are largely dodging the infectious diseases specialty, with 44 percent of ID programs left unfilled after the latest specialty fellowships Match Day on Nov. 30, NPR reported Dec. 12.
At the University of Washington in Seattle, which has one of the nation's top-ranked ID programs, administrators scrambled to find candidates for two spots that were still open after the match process
Progress toward an eventual HIV vaccine
December 13, 2022 - An experimental HIV vaccine elicited broadly neutralizing antibody precursors in people.
With further development, the approach could lead to an effective vaccine strategy for HIV and AIDS.
More than 1 million new HIV infections occur each year. Ending the global HIV/AIDS pandemic will require an effective HIV vaccine. Vaccines work by inducing the immune system to make antibodies that can neutralize a particular pathogen. But doing so for HIV has been challenging because there are countless variants worldwide, and the immune system doesn’t normally make antibodies that can protect against a wide range of them.
UNAIDS congratulates Barbados on its decision to repeal colonial-era laws that criminalised same sex sexual relations
GENEVA, 13 December 2022 - UNAIDS welcomes the judgement by the High Court in Barbados to strike down the country’s colonial-era gross indecency and buggery laws that criminalised consensual same-sex relations.
“This historic decision is a significant step towards protecting the human rights and dignity of LGBT people in Barbados,” said Luisa Cabal, UNAIDS Regional Director for Latin America and the Caribbean. “It will also strengthen the country’s HIV response by helping to reduce stigma and discrimination faced by LGBT people and increasing the uptake of HIV testing, treatment and prevention services.”
Medicaid expansion plus PrEP and antivirals could lower HIV transmission in Houston, model projects
Newswise — December 12, 2022 - Enacting Medicaid expansion in Texas and increasing the use of preventive and antiviral medications could result in a decline of new HIV infections among young Black gay, bisexual, and other men who have sex with men (MSM) in Houston, reports a study in the January issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Cindy Fair and Johanna Crump ’21 publish study in AIDS Care
December 12, 2022 – By Cynthia Fair - The qualitative study focused on parents' perspectives on the sexual and reproductive health of their internationally adopted child living with HIV.
Watts/Thompson Professor and Chair of the Department of Public Health Studies Cindy Fair and Public Health Studies alumna Johanna Crump ’21 have published a qualitative study examining parent perspectives of internationally adopted children with HIV (IACH).
Anthony Fauci: A Message to the Next Generation of Scientists
December 10, 2022 - Dr. Fauci is the director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Although I hesitate to use the hackneyed expression “It seems like just yesterday,” it does feel that way as I prepare to leave the National Institutes of Health after over five decades. As I look back at my career, I see lessons that may be useful to the next generation of scientists and health workers who will be called on to address the unexpected public health challenges that will inevitably emerge.
Read more...
16 Days of Activism: Combatting Gender-based Violence is Essential for HIV Response
LOS ANGELES--(BUSINESS WIRE) -- December 09, 2022 – For this year’s 16 Days of Activism, AIDS Healthcare Foundation (AHF) Africa Bureau urges collective action to turn the tide on gender-based violence (GBV) – especially violence against women and girls – which is essential for reducing new HIV infection rates and promoting retention in care and treatment among this demographic. This timely call-to-action mirrors the campaign’s 2022 global theme: “UNITE! Activism to end violence against women and girls.”
POZ Awards 2022 / Winners
December 9, 2022 - Here are the winners as voted by POZ readers!
Read more...
Rejection and fear of gay men was rampant in P.E.I. during HIV/AIDS epidemic, documentary shows
CHARLOTTETOWN, P.E.I. - Dec. 9, 2022 - Logan MacLean - George Clark-Dunning started planning his own funeral as soon as he got the news in 1992 that he was HIV positive.
“You have six months to live,” the doctor said.
Read more...
Pitt Men’s Study Hosts World AIDS Day Memorial to Honor Physician who Recruited Thousands to Help in Research
December 8, 2022 - By: Harry "Quincy" Nolan - The Pitt Men’s Study hosted its 35th annual World AIDS Day memorial last week to honor those who have lost their lives to HIV/AIDS-related illnesses. Moving from Heinz Chapel for the first time, the event was held at the Shepherd Wellness Community in an effort to emphasize community collaboration.
Penn Medicine at the 2022 ASH Meeting
NEW ORLEANS - December 08, 2022 - Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will be presenting data on the latest advances in blood cancer research and treatment at the 2022 American Society of Hematology (ASH) Annual Meeting from December 10-13. Watch this space as embargoes lift during the meeting.
Zambia Needs a Renewed Campaign Against HIV/AIDS
Dec. 8, 2022 - Fiske Nyirongo - Since reporting its first HIV/AIDS cases in the mid-1980s, Zambia has fought hard to eliminate the virus. As a major sign of progress, in December 2020, the Centre for Infectious Disease Research in Zambia announced that the country had reached its 90:90:90 target goal and was on the verge of attaining 95:95:95. This meant that of the estimated 1,300,000 Zambians living with HIV, 95% were aware of their status; 94.6% of those who were aware of their status were on treatment; and 94.2% of those on treatment were virally suppressed.
Read more...
Common medicine can stop the transmission of HIV infection from mother to child
December 8, 2022 - Antiviral drugs almost completely reduce the risk of mothers passing on HIV infection to their children, even in a low-income country with a high HIV incidence such as Tanzania, according to a new study in The Lancet HIV by researchers from Karolinska Institutet. The discovery raises hopes of achieving the World Health Organization’s goal of eliminating the spread of infection from mother to child.
The UN organization UNAIDS estimates eleven per cent of children born to HIV-positive mothers in Tanzania are infected with HIV in the womb, during childbirth or via breast milk. But that number is most likely significantly lower in reality, according to the new study.
ECDC and EMA collaborate on vaccine safety and effectiveness monitoring studies
Stockholm/Amsterdam, 8 December, 2022 - The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) convened on 6 and 7 December in Amsterdam the first meeting of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB) of the Vaccine Monitoring Platform (VMP).
The VMP is a joint initiative of the two Agencies for strengthening the continuous monitoring of the safety and effectiveness of vaccines in the European Union (EU).
Life goes on for people in Japan with HIV, but health care issues persist
Dec. 8, 2022 - BY EDUARDO MARTINEZ - Hiroto Okui’s HIV diagnosis took him completely by surprise.
“I never thought it could happen to me. I didn’t know what to do,” he says. The Tokyo native said it marked the beginning of an extremely difficult period.
Read more...
Clinician scientist receives NIH award to study interaction of mental health, HIV medication in Nigeria
December 7, 2022 - By MARCENE ROBINSON - The award will also provide Adedeji with mentorship and training at the University at Buffalo
Adedeji, also a scholar at the University at Buffalo Center for Integrated Global Biomedical Sciences (CIGBS), will receive mentorship and training through CIGBS as well.
Provided by the NIH Fogarty International Center, the Emerging Global Leader Award aims to support the career development of early career health scientists in low- and middle-income countries.
PrEP Far More Effective Than Sexual Abstinence In HIV Prevention: HIV Groups
KUALA LUMPUR, Dec 7 - By CodeBlue - PrEP is 99% effective in preventing HIV infection via sexual contact and 74% effective in reducing HIV transmission via injection drug use, say MAF, MAC, and MASHM.
HIV prevention drug PrEP far supersedes other prevention methods like condom use and abstinence in preventing HIV infection via sexual contact, HIV/AIDS groups said today.
The Malaysian AIDS Foundation (MAF), Malaysian AIDS Council (MAC), and the Malaysian Society for HIV Medicine (MASHM) pointed out that the pre-exposure prophylaxis (PrEP) oral medication is 99 per cent effective in reducing the chance of acquiring HIV via sexual contact and 74 per cent effective in reducing HIV transmission via injection drug use.
The people who need injectable HIV drugs most are the ones who can’t get them, BHIVA told
7 December 2022 - Gus Cairns - Injectable antiretroviral therapy will never reach its potential until people with unsuppressed viral loads can have it, the British HIV Association’s Autumn Conference heard last month in London.
Three presenters from the National HIV Nurses’ Association (NHIVNA) told the meeting that the criteria for injectable cabotegravir and rilpivirine were so strict that very few patients are eligible for them.
Read more...
Jones honored at World AIDS Day event
December 7, 2022 - by David-Elijah Nahmod - The rain didn't stop a crowd of more than 200 people from attending the National AIDS Memorial Grove's annual World AIDS Day observance in Golden Gate Park December 1, an event that saw AIDS Memorial Quilt co-founder Cleve Jones honored.
The observance took place in a large tent at the grove under the theme of "Changing the Pattern for a Future Without AIDS."
Read more...
Self-testing HIV kits now more readily available in northeastern Ontario
Dec 07, 2022 - Nathan Liewicki - HIV self-testing kits give results in 1 to 20 minutes
t's now easier for people in northeastern Ontario to test for HIV at home.
In August the Public Health Agency of Canada set aside $8 million for the distribution of HIV self-testing kits, and organizations in northern Ontario have started to benefit.
Read more...
AIDS ACTIVIST CALLS FOR A NATIONAL INQUIRY INTO THE OVERREPRESENTATION OF INDIGENOUS PEOPLE IN HIV CASES
(Winnipeg, MB) Dec. 6, 2022 - Dr. Albert McLeod - Long–time AIDS activist Dr. Albert McLeod is calling for a national inquiry to investigate the failed interventions and poor policies that have led to the dramatic increase of HIV among Indigenous people in Canada. On December 1, 2022, World AIDS Day, the Manitoba HIV Program released an overview of HIV statistics from 2018-2021. The number of people newly diagnosed with HIV and living in the province increased from 111 in 2018 to 169 in 2021, an increase of 52 per cent. Further, Dr. Ken Kasper estimates Manitoba will see more than 200 new diagnoses of HIV this year. Most of these cases are Indigenous people.
An HIV-free world is finally within reach
Dec. 6, 2022 - Ray Mwareya - But to get there we need to make sure that everyone, everywhere has equal access to groundbreaking new preventive drugs and treatments.
Today, truly, globally defeating HIV is indeed within reach thanks to miraculous new drugs and treatments already on the market and in development – but only if we work together and make sure that most efficient preventive drugs and treatments are available to everyone in need, anywhere in the world.
Read more...
GW Expert Notes Unequal Progress against AIDS on World AIDS Day
December 5, 2022 - by B.L. Wilson - At a GSEHD event, Jonathan Rendina of Milken Institute SPH talked about how lifesaving treatments for AIDS care and prevention are often blocked by stigma and lack of access to health care.
In commemoration of World AIDS Day, the George Washington University Graduate School of Education and Human Development (GSEHD) hosted a virtual discussion on the state of the AIDS epidemic that finds, according to the federal Centers for Disease Control and Prevention, more than 37 million people around the world and more than 1 million in the United States living with HIV.
Sharon Stone Says Backlash Over AIDS Activism 'Did Destroy My Career': 'I Had to Stick with It'
December 4, 2022 - By Glenn Garner - "I was threatened repeatedly, my life was threatened," Sharon Stone said of her time advocating
Sharon Stone says she sacrificed her career in the fight for HIV/AIDS research.
The Academy Award nominee, 64, said she "didn't work for eight years" after first taking over for late pal and then-amfAR chairwoman Elizabeth Taylor at the organization's annual Cannes fundraising gala in 1995, according to Deadline.
Read more...
HIV ‘drug factory’ implant promises once-a-year therapy
Dec. 2, 2022 - Mike Williams - Bioengineer Omid Veiseh receives grant from Bill & Melinda Gates Foundation
A Rice University laboratory, with a boost from the Bill & Melinda Gates Foundation, will develop a once-a-year treatment for patients infected with HIV and other infectious diseases.
The Rice lab of bioengineer Omid Veiseh has received a $3 million foundation grant to develop implants that produce and deliver monoclonal anti-HIV antibody (mAb) therapeutics for at least a year. Michael Diehl, an associate professor of bioengineering and chemistry at Rice, is co-investigator on the grant.
Scientists reveal encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach
NEW YORK and LA JOLLA, CA — DECEMBER 2, 2022 - Scripps Research, IAVI, Fred Hutch, VRC and other collaborators publish study data in Science, helping validate novel vaccination strategy.
While scientists have struggled in the past to create an effective vaccine against HIV, a novel vaccine design strategy being pursued by researchers at Scripps Research, IAVI, Fred Hutchinson Cancer Center (Fred Hutch) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) shows new promise, according to data from a first-in-human clinical trial.
In a paper published in Science on December 2, 2022, the scientists reveal critical new insights into their novel vaccine strategy, which involves a stepwise approach to producing antibodies capable of targeting a wide range of HIV variants.
Patti LaBelle, Gladys Knight, Soar at AHF’s Kennedy Center World AIDS Day Concert
LOS ANGELES, CA (December 2, 2022) - By Ged Kenslea - The AIDS Healthcare Foundation (AHF) hosted its 2022 World AIDS Day Concert on Wednesday, November 30th, at the prestigious concert hall of The Kennedy Center in Washington D.C. Renowned multi-GRAMMY Award-winning vocalists Patti LaBelle and Gladys Knight delivered show-stopping performances to the packed crowd, which included supporters, dignitaries such as: Harold Phillips, Director of the White House Office of National AIDS Policy; White House Senior Advisor for Public Engagement, Mayor Keisha Lance Bottoms, Congresswoman Sheila Jackson Lee, and New Orleans Mayor, Mayor LaToya Cantrell, and more, in a night of hope and celebration.
HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’
December 2, 2022 - By Jacqueline Howard - An experimental HIV vaccine has been found to induce broadly neutralizing antibody precursors among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
Read more...
Reflecting on my 40 years living with HIV
December 1, 2022- Jesse Milan Jr. - On World AIDS Day, I’m usually asked to represent and focus on all the people in the past who have suffered and died from AIDS, on all in those past and the present who have been diagnosed with HIV, and on all who have labored and fought over the decades for the health and well-being of people living with and vulnerable to HIV.
STATEMENT: Human Rights Campaign Marks World AIDS Day 2022
WASHINGTON - December 1, 2022 - Human Rights Campaign remembers those lost and pushes for equitable access to healthcare on the 34th World AIDS Day
Today, the Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, marked World AIDS Day 2022 with a statement from Kelley Robinson, President of the Human Rights Campaign
Canada must redouble its commitment to AIDS treatment
December 1, 2022 - JULIO MONTANER - On this World AIDS Day, as we reflect on the lasting impact of HIV/AIDS over the past 40 years, we are at a precipice where all the strides made are in jeopardy.
The tide started to turn initially against the HIV/AIDS epidemic in 1996 when we unveiled highly active antiretroviral therapy, or HAART, the first effective means to prevent the progression of HIV infection to AIDS and premature deaths.
Read more...
New data says more Manitobans getting HIV, with higher proportions of women, Indigenous people
Dec 1, 2022 - Nathan Liewicki - Report by Manitoba HIV Program sheds light on who's been diagnosed over last 4 years
Manitoba has seen a sharp increase in HIV rates over the past four years — and the doctors who have been tracking the data say the situation is likely to get worse.
The Manitoba HIV Program unveiled its 2018-2021 report findings Thursday — World AIDS Day and Indigenous Awareness Week — by highlighting an overrepresentation of Indigenous people living with HIV, and more women being diagnosed.
Read more...
ViiV Healthcare unveils a new global study revealing three quarters of people believe there are still negative perceptions when it comes to people living with HIV
London, 1 December 2022 - On World AIDS Day 2022, ViiV Healthcare releases data from a survey investigating outdated attitudes towards HIV as part of the ‘HIV in View’ campaign
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from a perceptions survey which unveils a widespread gap in public knowledge and understanding of HIV worldwide. The data found that three quarters of people (74%) believe that there are still negative perceptions when it comes to people living with HIV, and that one in six adults agree that if a friend or colleague was living with HIV, they might look at them negatively. While the majority of people surveyed did report feeling comfortable with physical contact, including holding hands (76%) or hugging (75%), only 1 in 2 people would feel comfortable dating someone living with HIV. Concerningly, the survey also found that a quarter of adults (25%) believe that it is not appropriate for employees to talk about HIV in the workplace, a factor continuing to perpetuate HIV as a taboo subject.
Influenza season epidemic kicks off early in Europe as concerns over RSV rise and COVID-19 is still a threat
1 December 2022 - Joint statement by Commissioner for Health and Food Safety Stella Kyriakides, WHO Regional Director for Europe Dr Hans Henri P. Kluge and Director of the European Centre for Disease Prevention and Control Dr Andrea Ammon
The 2022-2023 influenza (flu) season epidemic is off to an early start in the European region as concerns over respiratory syncytial virus (RSV) rise and COVID-19 is still being a threat.
HIV activists hope World AIDS Day marks an end to backsliding on infections, stigma
Dec. 1, 2022 - THE CANADIAN PRESS - Public Health Agency of Canada estimated 62,790 Canadians were living with HIV in 2020
As Canadians marked World AIDS Day on Thursday, one volunteer at a Montreal housing facility shared his story about the centre that he says has been a life-changer for so many people.
Read more...
Infographic: World AIDS Day 2022
Dec. 1, 2022 - By AJLabs - Around the world, every week about 4,900 young women aged between 15 and 24 become infected with HIV.
According to UNAIDS, in 2021, some 1.5 million people became newly infected with HIV, bringing the total number of people living with HIV to 38.4 million.
Read more...
New HealthyWomen and NCBA HIV & Aging Survey Finds Nearly Half of Americans Falsely Believe Older Adults Are Not at Risk for HIV
December 1, 2022 - HealthyWomen, the nation’s leading independent nonprofit health resource for women, recently conducted a national survey of more than 4,000 respondents in partnership with he National Caucus and Center of Black Aging (NCBA). The survey assessed people’s understanding of HIV and aging, including diagnosis, treatment, testing, stigma and barriers to care, specifically for those 50 years or older in the United States. Surprisingly, nearly one-third of the respondents incorrectly believe women do not have to worry about getting HIV after going through menopause. Almost half of those surveyed (46%) also believe older adults who are sexually active with new partners are not at risk of contracting HIV. In fact, according to the Centers for Disease Control and Prevention (CDC), in 2018, over half of the people in the United States diagnosed with HIV were 50 and older.
World AIDS Day: A look inside a Montreal shelter for people living with HIV/AIDS
Dec. 1, 2022 - Rob Lurie - As Canadians marked World AIDS Day on Thursday, one volunteer at a Montreal housing facility shared his story about the centre that he says has been a life-changer for so many people.
Read more...
World Aids Day: Why the Middle East lags behind in fighting HIV
December 1, 2022 - By Hossam Fazulla -BBC Arabic - The number of new HIV cases worldwide has decreased significantly over the last decade - but in the Middle East and North Africa (Mena), however, it is a different story.
The world has come a long way since the peak of the HIV/Aids epidemic - which has so far claimed more than 40 million lives - in 1996.
Read more...
Most Canadians don't know a person with HIV can't sexually transmit virus if taking proper medication: survey
Dec. 1, 2022 - Alexandra Mae Jones -Only one in five Canadians are aware that a person with HIV can’t sexually transmit the disease if they are taking the proper medication, according to a new survey that suggests Canadians still have a long way to go in understanding the medical and social realities of HIV.
Read more...
Windsor advocacy group and health unit fight stigma on World AIDS Day
Windsor - Dec 01, 2022 - 'Stigma is one of the largest barriers in terms of accessing care,' says AIDS/HIV support advocate
The number of people diagnosed with HIV/AIDS in Windsor-Essex has plateaued, but according to Michael Brennan, executive director of Windsor-Essex HIV/AIDS advocacy group, Pozitive Pathways, there is still a disconnect between diagnosis and treatment in marginalized communities.
Read more...
The impact of COVID-19 on HIV research
01 DEC 2022 - While the last almost three years have been centred on the global COVID-19 pandemic, we mustn’t forget that the world has been fighting another pandemic for the past four decades.
University of Melbourne’s Professor Sharon Lewin, Director of the Doherty Institute, leader in research for an HIV cure and President of the International AIDS Society (IAS), dubbed HIV “the biggest pandemic the world has ever seen.”
On World AIDS Day, Canada must lead the way in combating HIV-AIDS
December 1, 2022 - Julio Montaner - Viviane Dias Lima - Dec. 1 marks World AIDS Day. As researchers focused on fighting the HIV-AIDS epidemic, we are increasingly concerned all the progress made in the fight against the virus is at risk.
In 1996, the first remarkable breakthrough against the HIV-AIDS epidemic came with the novel combination of drugs that became known as Highly Active Antiretroviral Therapy (HAART).
FACT SHEET: The Biden-Harris Administration’s Efforts to End HIV/AIDS At Home and Abroad
December 1, 2022 - On World AIDS Day, we reflect on all those lost globally and in the U.S. from AIDS-related illnesses, honor the more than 38 million individuals living with HIV, and celebrate the remarkable gains we have made battling this disease. The Biden-Harris Administration remains committed to implementing the updated National HIV/AIDS Strategy (NHAS) announced last year and achieving the bipartisan goal of ending the HIV epidemic at home and abroad. The Administration is also releasing a new strategy to guide the President’s Emergency Plan for AIDS Relief (PEPFAR) globally.
HIV activists hope World AIDS Day marks an end to backsliding on infections, stigma
OTTAWA - Dec. 1, 2022 - Opinion: Where we are falling behind is in linking those diagnosed with HIV to followup care and treatment. This is disturbing for many reasons.
One of the silver linings of the COVID-19 pandemic has been the number of things you can now do from the comfort of your own home. From telework to talking to a doctor, the last two years have revolutionized what is possible.
Read more...
A Proclamation on World AIDS Day, 2022
December 1, 2022 - On World AIDS Day, we recommit to ending the HIV epidemic in the United States and around the world and rededicate ourselves to fighting the discrimination that too often keeps people with HIV from getting the services they need and living the full lives they deserve.
HIV research and art intersect in a powerful way
WORLD AIDS DAY, Dec 1, 2022 - Oral history captures the stories of people left out of mainstream historical narratives. Verbatim theatre transforms those words into art.
HIV In My Day, a community-based oral history project that gathered the stories of HIV survivors and caregivers during the early years of BC’s HIV/AIDS epidemic, has been adapted into In My Day, a play that premieres at Vancouver’s The Cultch theatre Dec. 2, the day after World AIDS Day. The play’s script draws from almost 120 interviews recorded between 2017 and 2020 as part of a University of Victoria-led research project.
Canadian HIV/AIDS and Chronic Pain Society Opens its Doors, December 1, 2022
WORLD AIDS DAY, Dec 1, 2022 - The Canadian HIV/AIDS and Chronic Pain Society will collaborate with persons living with HIV/AIDS (PLWH), populations at risk, AIDS Service organizations, peer and frontline workers, healthcare professionals, researchers, government, and multi-level stakeholders to improve our knowledge and access to HIV and comorbidity pain treatment, care, and support in Canada. We will also advocate for research funding, partnerships, and government assistance for chronic pain and HIV research.
|
